Page last updated: 2024-10-24

chlorambucil and Eperythrozoonosis

chlorambucil has been researched along with Eperythrozoonosis in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jouanneau, M1
Brouilhet, H1
Kahan, A1
Charles, A1
Delbarre, F1

Other Studies

1 other study available for chlorambucil and Eperythrozoonosis

ArticleYear
The effect of immunosuppression on polyarthritis induced by Mycoplasma arthritidis in rats.
    Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1973, Apr-10, Volume: 19, Issue:4

    Topics: Animals; Arthritis; Azathioprine; Chlorambucil; Cyclophosphamide; Immune Sera; Immunosuppressive Age

1973